We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Approves Revlimid; Celgene Eyeing Early 2006 Launch
FDA Approves Revlimid; Celgene Eyeing Early 2006 Launch
December 28, 2005
The FDA has approved Celgene’s blood disorder treatment Revlimid, clearing the way for the firm to begin initial shipments of the drug in early 2006.